Flavopiridol inducesBCL-2expression and represses oncogenic transcription factors in leukemic blasts from adults with refractory acute myeloid leukemia-Reference-Cited by-同舟云学术

Flavopiridol inducesBCL-2expression and represses oncogenic transcription factors in leukemic blasts from adults with refractory acute myeloid leukemia

Published:2011-07-05 Issue:10 Volume:52 Page:1999-2006
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Nelson Dwella M.,Joseph Biju,Hillion Joelle,Segal Jodi,Karp Judith E.,Resar Linda M. S.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2011.591012

Reference52 articles.

1. Acute Myeloid Leukemia

2. Drug therapy for acute myeloid leukemia

3. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs

4. New agents in acute myeloid leukemia: Beyond cytarabine and anthracyclines

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HMGA1 induces FGF19 to drive pancreatic carcinogenesis and stroma formation;Journal of Clinical Investigation;2023-03-15

2. Ligand- and structure-based identification of novel CDK9 inhibitors for the potential treatment of leukemia;Bioorganic & Medicinal Chemistry;2022-10

3. HMGA1 chromatin regulators induce transcriptional networks involved in GATA2 and proliferation during MPN progression;Blood;2022-05-05

4. Interrogation of novel CDK2/9 inhibitor fadraciclib (CYC065) as a potential therapeutic approach for AML;Cell Death Discovery;2021-06

5. Phase I Study of Alvocidib Followed by 7+3 (Cytarabine + Daunorubicin) in Newly Diagnosed Acute Myeloid Leukemia;Clinical Cancer Research;2020-09-30